Muja Naser, DeVries George H
Neuroscience Graduate Program, Neurobiology, and Anatomy Loyola University of Chicago, Maywood, Illinois, USA.
Glia. 2004 Apr 15;46(2):116-29. doi: 10.1002/glia.10349.
Sciatic nerve explants cultured either alone or in the presence of peritoneal macrophages were used to study prostaglandin E(2) (PGE(2)) and 6-keto-PGF(1alpha) production following traumatic peripheral nerve injury. Although barely detectable at early time points (1-3 h in vitro), the production of PGE(2) and 6-keto-PGF(1alpha) by sciatic nerve explants increased significantly after 18 h and remained elevated for up to 96 h. The cyclooxygenase-2 (COX-2) selective inhibitor, NS-398, inhibited PGE(2) and 6-keto-PGF(1alpha) production by injured sciatic nerve in a dose-dependent manner. Consistent with the observed effect of NS-398, peripheral nerve explants, as well as Schwann cells and perineural fibroblasts cultured from neonatal sciatic nerve, each contained COX-2 immunoreactivity after 24 h in vitro. Both Schwann cells and perineural fibroblasts produced significant amounts of PGE(2) and 6-keto-PGF(1alpha); but only in the presence of arachidonic acid. As observed for injured sciatic nerve, the production of PGE(2) and 6-keto-PGF(1alpha) by primary Schwann cells and perineural fibroblasts was completely inhibited by NS-398. Compared to macrophages cultured alone, macrophages cultured in the presence of sciatic nerve explants produced large amounts of PGE(2), whereas the level of 6-keto-PGF(1alpha) was unchanged. In contrast, macrophages treated with adult sciatic nerve homogenate did not produce significant amounts of either PGE(2) or 6-keto-PGF(1alpha) during the entire course of treatment. We conclude that injured sciatic nerves produce PGE(2) and 6-keto-PGF(1alpha) by a mechanism involving COX-2 activity and that macrophages produce large amounts of PGE(2) in response to soluble factors produced by injured nerve but not during the phagocytosis of peripheral nerve debris.
将坐骨神经外植体单独培养或在腹膜巨噬细胞存在的情况下培养,用于研究创伤性周围神经损伤后前列腺素E2(PGE2)和6-酮-前列腺素F1α(6-keto-PGF1α)的产生。尽管在早期时间点(体外1-3小时)几乎检测不到,但坐骨神经外植体产生的PGE2和6-keto-PGF1α在18小时后显著增加,并持续升高至96小时。环氧化酶-2(COX-2)选择性抑制剂NS-398以剂量依赖性方式抑制损伤坐骨神经产生PGE2和6-keto-PGF1α。与NS-398的观察效果一致,外周神经外植体以及从新生坐骨神经培养的雪旺细胞和神经周成纤维细胞在体外培养24小时后均含有COX-2免疫反应性。雪旺细胞和神经周成纤维细胞均产生大量的PGE2和6-keto-PGF1α;但仅在花生四烯酸存在的情况下。如在损伤的坐骨神经中观察到的那样,NS-398完全抑制原代雪旺细胞和神经周成纤维细胞产生PGE2和6-keto-PGF1α。与单独培养的巨噬细胞相比,在坐骨神经外植体存在的情况下培养的巨噬细胞产生大量的PGE2,而6-keto-PGF1α的水平没有变化。相比之下,用成年坐骨神经匀浆处理的巨噬细胞在整个处理过程中均未产生大量的PGE2或6-keto-PGF1α。我们得出结论,损伤的坐骨神经通过涉及COX-2活性的机制产生PGE2和6-keto-PGF1α,并且巨噬细胞响应损伤神经产生的可溶性因子而产生大量的PGE2,但在吞噬周围神经碎片期间不产生。